Top Portfolio Products: Direxion Launches Income Fund, Closes Gold-Bear ETF
In addition, Palmer Square rolls out a long/short credit fund; Capital adds long/short equity product.
Chinese Communists More Market-Friendly Than U.S.: George Gilder
I sat down with the free-market conservative Gilder to discuss why his views appear to be “out of favor,” to put it in investment-speak.
What a Major Coverage Denial Says About Medicare's Future
A recent decision to disallow coverage of a newly FDA-approved PET scan could have widespread ramifications for patients needing new, innovative treatments.
SEC, FINRA Enforcement: StateTrust Investments Fined for Corporate Bond Fraud
Among recent enforcement actions, FINRA ordered StateTrust Investments to pay more than $1.3 million for excessive markups and markdowns in corporate bond transactions.
Tainted Honey Sticking It to Global Investors, Consumers
There are many ways investors can get stung on Asian investments—but there can be sweet opportunities, too
Food Prices Likely to Stay Higher
The effects of droughts in the U.S. and Russia that have driven food prices higher are likely to last for the next six months, according to the U.N., and the global food market will be in “short supply mode.”
Solid growth and promising research and development pipelines bode well for companies that sell pharmaceutical and related health-care products.
Fiduciary Debate: What if Doctors Could Act Like Advisors?
Wherein our intrepid blogger applies the logician's reductio ad absurdum argument to the current debate over applying the fiduciary standard to brokers, or not.
PlanTools Releases Retirement Plan Expense Benchmark Study
To fully understand whether their costs are "reasonable," plan sponsors must have reliable and accurate data upon which to base their conclusions.
High Hopes and Altered Genes
Biotech has long been a high-risk, high-reward industry. It is an industry in which numerous firms, including many small-caps and start-ups, intensively research possible...